Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipanperidone vs risperidone in schizophrenia
CTR20140091Phase 2Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iloperidone in schizophrenia, sponsored by CSPC Pharmaceutical Group. Started Apr 2014; status: completed.
02
Drugs
iloperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20140091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140091.